[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE310089T1 - Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen - Google Patents

Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen

Info

Publication number
ATE310089T1
ATE310089T1 AT00956336T AT00956336T ATE310089T1 AT E310089 T1 ATE310089 T1 AT E310089T1 AT 00956336 T AT00956336 T AT 00956336T AT 00956336 T AT00956336 T AT 00956336T AT E310089 T1 ATE310089 T1 AT E310089T1
Authority
AT
Austria
Prior art keywords
white spot
spot syndrome
syndrome virus
derived proteins
virus derived
Prior art date
Application number
AT00956336T
Other languages
English (en)
Inventor
Hulten Maria Cornelia Wilh Van
Justinus Maria Vlak
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE310089T1 publication Critical patent/ATE310089T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00956336T 1999-08-03 2000-07-26 Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen ATE310089T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202545 1999-08-03
EP00200248 2000-01-24
PCT/EP2000/007290 WO2001009340A1 (en) 1999-08-03 2000-07-26 Proteins derived from white spot syndrome virus and uses thereof

Publications (1)

Publication Number Publication Date
ATE310089T1 true ATE310089T1 (de) 2005-12-15

Family

ID=26071765

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956336T ATE310089T1 (de) 1999-08-03 2000-07-26 Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen

Country Status (14)

Country Link
US (2) US7749506B2 (de)
EP (1) EP1206550B1 (de)
JP (1) JP4786093B2 (de)
CN (2) CN1626241A (de)
AT (1) ATE310089T1 (de)
AU (1) AU771049B2 (de)
BR (1) BR0012919A (de)
CA (1) CA2380833C (de)
DE (1) DE60024100D1 (de)
EC (1) ECSP093601A (de)
MX (1) MXPA02001223A (de)
MY (1) MY131143A (de)
TW (1) TWI266802B (de)
WO (1) WO2001009340A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU780206B2 (en) * 2000-09-15 2005-03-10 Intervet International B.V. Antigenic proteins of shrimp white spot syndrome virus and uses thereof
WO2003000900A1 (en) * 2001-06-22 2003-01-03 Akzo Nobel N.V. White spot syndrome virus vaccine
US7550647B2 (en) 2001-09-14 2009-06-23 Advanced Bionutrition Transfected shrimp as production systems for therapeutic proteins
EP1545600A4 (de) * 2002-09-16 2006-07-12 Advanced Bionutrition Corp Protein- und peptid-expression für passive immunität
KR100489617B1 (ko) * 2002-09-24 2005-05-17 주식회사 단바이오텍 흰반점바이러스 감염의 예방 및 치료를 위한 수용성 항체단백질 및 이를 포함한 알, 및 이들의 제조방법
BRPI0412282A (pt) * 2003-07-02 2006-09-19 Musc Found For Res Dev imunidade especìfica e não-especìfica induzida de dsrna em crustáceos e outros invertebrados, e veìculos de bioliberação para uso nestes
AU2004271211A1 (en) * 2003-09-09 2005-03-17 Aqua Bounty Technologies, Inc. Compositions and methods for inhibiting White Spot Syndrome Virus (WSSV) infection
CN101023095B (zh) * 2004-07-09 2013-07-03 绿色生命实验室有限公司 基因工程蛋白质p40及其应用
JP2008169131A (ja) * 2007-01-10 2008-07-24 Univ Of Miyazaki 甲殻類急性ウイルス血症に対するｄｎａワクチン
JP5649188B2 (ja) * 2009-07-09 2015-01-07 国立大学法人 宮崎大学 クルマエビ科生物の急性ウイルス血症に対するワクチン
CN101691403B (zh) * 2009-08-03 2011-11-09 中国海洋大学 抗对虾白斑症病毒囊膜蛋白vp28独特型单克隆抗体及其制备方法
CN102647988A (zh) 2009-10-02 2012-08-22 纽约市哥伦比亚大学理事会 鱼呼肠弧病毒免疫原性组合物
US8822427B2 (en) 2010-10-27 2014-09-02 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
US8828961B2 (en) 2010-10-27 2014-09-09 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
MY161995A (en) * 2010-11-10 2017-05-31 Univ Malaya Vaccine against white spot syndrome virus
MY153741A (en) 2010-11-10 2015-03-13 Univ Malaya A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof
CN109517037B (zh) * 2018-10-31 2022-02-08 青岛科技大学 具有白斑综合征病毒抑制作用的多肽及其应用
CN109821013B (zh) * 2018-12-17 2022-06-14 潍坊麦吉迪生物科技有限公司 抗对虾白斑病疫苗及其制备方法
JPWO2022158453A1 (de) * 2021-01-20 2022-07-28
KR102699731B1 (ko) * 2021-06-18 2024-08-28 국립부경대학교 산학협력단 흰 반점 증후군 바이러스 외피 단백질을 발현하는 형질전환 미세조류를 유효성분으로 포함하는 흰 반점 증후군의 예방 또는 개선용 사료첨가제 조성물 및 이의 용도
CN114600811A (zh) * 2022-04-21 2022-06-10 中国水产科学研究院黄海水产研究所 一种中国对虾核心育种群wssv的净化方法
CN117701777A (zh) * 2024-01-22 2024-03-15 烟台海关技术中心 WSSV检测引物、crRNA、CRISPR组合物、试剂盒及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA934893B (en) * 1992-07-20 1995-01-09 Colgate Palmolive Co Gelled organic liquids
US5824535A (en) * 1996-01-17 1998-10-20 Kou; Guang-Hsiung Identification, purification and detection of WSBV (Baculovirus associated with white spot syndrome)
JPH09201196A (ja) * 1996-01-25 1997-08-05 Koyu Kaku 白斑症候群関連バキュロウイルスの同定、精製および検出

Also Published As

Publication number Publication date
US20100324125A1 (en) 2010-12-23
US8114977B2 (en) 2012-02-14
ECSP093601A (es) 2009-08-28
AU6832000A (en) 2001-02-19
BR0012919A (pt) 2002-04-23
CN1170934C (zh) 2004-10-13
CN1367834A (zh) 2002-09-04
CA2380833A1 (en) 2001-02-08
MXPA02001223A (es) 2002-07-30
TWI266802B (en) 2006-11-21
US7749506B2 (en) 2010-07-06
MY131143A (en) 2007-07-31
US20090068212A1 (en) 2009-03-12
EP1206550B1 (de) 2005-11-16
JP2003506338A (ja) 2003-02-18
CA2380833C (en) 2011-03-15
CN1626241A (zh) 2005-06-15
AU771049B2 (en) 2004-03-11
EP1206550A1 (de) 2002-05-22
DE60024100D1 (de) 2005-12-22
JP4786093B2 (ja) 2011-10-05
WO2001009340A1 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
ATE310089T1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
AP1770A (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their sythesis.
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
EA199901031A1 (ru) Производные бензимидазола
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
EP1408986A4 (de) Proteomimetische verbindungen und verfahren
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
MXPA03000626A (es) Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de la hepatitis c.
BRPI0309631A8 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3 e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
EA200200820A1 (ru) Пептиды, полученные из казеина, и их применение в терапии
EA200500019A1 (ru) Ксиланазы, кодирующие их нуклеиновые кислоты и способы их получения и применения
ATE427116T1 (de) Behandlung von bakteriellen infektionen
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
ATE382685T1 (de) Bakteriophagen-lysin
ATE412666T1 (de) Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
TR200102024T2 (tr) Yeni tedavi.
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
EA200500533A1 (ru) Пептидные производные - ингибиторы слияния при вич-инфекции
PT1411956E (pt) Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih
ATE255594T1 (de) Hepatitis b inhibitoren
BR0112123A (pt) Composto

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties